ComPro Pharma
ActiveComPro Pharma has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9k and a net result of €54k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 20% of 509 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency12▼-5
Growth70=
Stability100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
Liquidity short (current ratio 0.69 against 0.94 in 2024), and 88.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
11.9%
Return on assets
70.6%
Age of the figures
8 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 509 sector peers (2025).
NBB · sector comparisonPosition among 509 sector peers
Solvency
better than 20%
← weakest
strongest →
lowers risk · Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
NBB · annual accounts 2025Equity per financial year
202122232425
2020 to 2025 · latest year €9k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
64 d early
2024
41 d early
2023
5 d early
2022
49 d early
2021
3 d early
2020
on the day
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
07-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€161k▲ 10.4%
2022 · €146k
2020: €96k
2021: €145k
2022: €146k
2020 → 2023
EBIT margin
44.7%▲ 5.7pp
2022 · 39.0%
2020: 47.0%
2021: 41.9%
2022: 39.0%
2020 → 2023
Net result
€54k▼ 4.6%
2024 · €57k
2020: €35k
2021: €48k
2022: €44k
2023: €56k
2024: €57k
2020 → 2025
Working capital
€-21k▼ 404%
2024 · €-4k
2020: €39k
2021: €87k
2022: €131k
2023: €7k
2024: €-4k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€145k-€146k▲ 0.2%€161k▲ 10.4%
Equity€87k-€131k▲ 50.6%€7k▼ 94.7%€9k▲ 27.1%€9k▲ 3.4%
Operating result€61k-€57k▼ 6.8%€72k▲ 26.6%€72k▲ 0.1%€70k▼ 3.2%
Net result€48k-€44k▼ 7.6%€56k▲ 27.3%€57k▲ 1.6%€54k▼ 4.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 3% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €77k
Fixed assets
€30k▲ 130%
Current assets
€47k▼ 32.0%
Equity and liabilities €77k
Equity
€9k▲ 3.4%
Debt
€68k▼ 7.5%
The debt ratio falls from 89.2% to 88.1%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€77k▲
2024 · €74k
Cash flow
€62k▲
2024 · €59k
Solvency
11.9%▲
2024 · 10.8%
Current ratio
0.69▼
2024 · 0.94
Quick ratio
0.69▼
2024 · 0.94
Debt / equity
7.38▼
2024 · 8.25
ROE
592.1%▼
2024 · 641.3%
ROA
70.6%▲
2024 · 69.4%
Interest coverage
373.75▲
2024 · 364.77
Debt
€68k▼
2024 · €73k
Debt ≤ 1 year
€68k▼
2024 · €73k
Income taxes
€15k▼
2024 · €16k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Total assets20/58€82k€77k▼
Fixed assets21/28€13k€30k▲
Tangible fixed assets22/27€13k€7k▼
Financial fixed assets28-€23k
Current assets29/58€69k€47k▼
Amounts receivable within one year40/41€16k€16k=
Cash & bank54/58€51k€30k▼
Total equity & liabilities10/49€82k€77k▼
Equity10/15€9k€9k▲
Contributions / capital10/11€4k€4k=
Accumulated profits (losses)14€5k€5k▲
Amounts payable17/49€73k€68k▼
Amounts payable within one year42/48€73k€68k▼
Trade debts payable within one year44€2k€1k▼
Income statement
Code20242025
Gross operating margin9900€75k€78k▲
Operating result9901€72k€70k▼
Financial income75€871€173▼
Financial charges65€202€206▲
Result before taxes9903€73k€70k▼
Income taxes67/77€16k€15k▼
Net result for the period9904€57k€54k▼
Result to be appropriated9905€57k€54k▼
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
20-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2020net €57k ▲1.6%
Operating result €72k, net result €57k, both a record.
26-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
12-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €100kEq €131k ▲50.6%
3 profitable years in a row build equity to €131k.
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Comparable companies · same sector, comparable size
Similar companies · same sector, comparable size
ALLSIGHTSAFRICA
BE 0756.899.314
Orp-Jauche · Eq €9k
1ML Consultancy
BE 1027.960.369
Begijnendijk · Eq €9k
SYMPLI GOOD FOOD
BE 0671.744.794
Gent · Eq €10k
BOKSTEEN AQUACULTURE
BE 0649.878.620
Gent · Eq €10k
Gojie
BE 1018.681.528
Leuven · Eq €10k
Of 753 companies in sector 72101 we hold annual accounts for 476. 123 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded21-04-2020
Fiscal year end31-12
Activities, NACEBEL
72101Research and development on biotechnology
70200Business and other management consultancy
70220Business consulting
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 24-07-2026. Scores and ratios are computed by Checked and are not a credit decision.